The revenue stands at ₹14,611.79 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 5.86 per cent from ₹15,520.54 crore. This corresponds to a year-on-year *(YoY) growth of 12.76 per cent.
Operating Profit stands at ₹3,954.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.32 per cent from ₹4,459.01 crore. This corresponds to a year-on-year *(YoY) growth of 17.88 per cent.
PBDT stands at ₹4,312.75 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.69 per cent from ₹4,939.57 crore. This corresponds to a year-on-year *(YoY) growth of 10.26 per cent.
Profit Before Tax stands at ₹3,537.28 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 15.92 per cent from ₹4,207.24 crore. This corresponds to a year-on-year *(YoY) growth of 8.92 per cent.
Net Profit stands at ₹2,709.66 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.86 per cent from ₹3,381.17 crore. This represents a 25.80 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | 0.98% | 2.91% | 7.55% | 14.51% | 16.09% | 12.45% |
| Divi's Lab. | 3.81% | 6.40% | 8.79% | 16.39% | 17.06% | 5.90% |
| Torrent Pharma. | 0.49% | 2.15% | 10.27% | 19.64% | 21.54% | 44.56% |
| Cipla | 0.62% | 0.32% | 3.97% | 17.09% | 2.74% | -3.66% |
Chairman & Managing Director : Dilip S Shanghvi
Non Executive & Independent Director : Gautam Doshi
Lead Independent Director : Pawan Goenka
Independent Director : Rama Bijapurkar
Company Sec. & Compli. Officer : Anoop Deshpande
Independent Director : Rolf Hoffmann
Whole Time Director & Chief Operating Officer : Aalok Shanghvi
Whole Time Director : Vidhi Shanghvi
Managing Director : Kirti Wardhaman Ganorkar
Independent Director : Satyavati Berera